What is the Infectious Diseases Clinical Trials Unit?

The Ohio State Infectious Diseases Clinical Trials Unit is one of 34 sites nationwide that conduct federally sponsored research studies for the treatment of HIV and AIDS, COVID-19, and other infectious diseases. The unit is staffed by an expert, multidisciplinary team of health care professionals.

At the IDCTU, volunteers may participate in studies that contribute to improving treatment outcomes and managing drug resistance, preventing and treating co-infections, and contribute to our increasing knowledge of treatment as prevention for HIV. Volunteers may also participate in COVID-19 related treatment studies and vaccine trials.

AIDS Education and Training Centers

Ohio State’s AIDS Education and Training Center (AETC) within the Infectious Diseases Clinical Trials Unit is among a national network of centers conducting multidisciplinary education and training programs for health care providers treating individuals with HIV/AIDS. AETC services help improve the quality of life for individuals with HIV/AIDS.

Community Advisory Board – A Voice for Our Volunteers

As part of the federally funded AIDS Clinical Trials Group, Ohio State’s IDCTU has a Community Advisory Board. This board provides advocacy and partnerships for affected communities, especially clinical trial participants. We encourage participants to ask questions about the research process and share their ideas and concerns.

If you are interested in participating in research at Ohio State’s Infectious Diseases Clinical Trials Unit, call 614-293-8112 and speak with our screening nurse. All information is strictly confidential.

Types of studies


At the IDCTU, volunteers may participate in a wide variety of studies that contribute to improving treatment for HIV, including new therapies and managing drug resistance, preventing and treating co-infections and contribute to our increasing knowledge of treatment as prevention. Since the start of COVID-19 pandemic, the IDCTU opened up studies that contribute to the discovery of new vaccines and medications for the novel disease.

Find active studies

Our Leaders

Our leaders

Koletar_Susan_724x840

Susan L. Koletar, MD, FACP, FIDSA

Director, Division of Infectious Diseases

Principal Investigator, Infectious Diseases Clinical Trials Unit (IDCTU)
Pomerene Professor, Infectious Diseases
Professor, Internal Medicine

View my bio

View research bio

Para_Michael_724x840

Michael F. Para, MD

Co-Principal Investigator, Infectious Diseases Clinical Trials Unit (IDCTU)

Professor Emeritus, Infectious Diseases
Professor Emeritus, Molecular Virology, Immunology and Medical Genetics
Physician-FGP, Infectious Diseases

View my bio

View research bio

Maher_William_724x840

William E. Maher, MD

Associate Professor, Internal Medicine

Retiree-Faculty Emeritus, Infectious Diseases
Physician, FGP-Infectious Diseases

View my bio

View research bio

Wininger_David_724x840

David A. Wininger, MD

Associate Professor, Internal Medicine

Program Director, Internal Medicine Residency Program
Associate Professor-Clinical, Infectious Diseases
Physician, FGP-Infectious Diseases

View my bio

View research bio

IDCTU Staff

IDCTU Staff

IDCTU/AETC Staff

IDCTU/AETC Staff

Share this Page